These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16518530)

  • 1. Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects.
    Marketou ME; Zacharis EA; Nikitovic D; Ganotakis ES; Parthenakis FI; Maliaraki N; Vardas PE
    Angiology; 2006; 57(2):211-8. PubMed ID: 16518530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.
    Kowalski J; Okopień B; Madej A; Zieliński M; Belowski D; Kalina Z; Herman ZS
    Eur J Clin Pharmacol; 2003 Jul; 59(3):189-93. PubMed ID: 12756509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin.
    Lampl Y; Lorberboym M; Gilad R; Vysberg I; Tikozky A; Sadeh M; Boaz M
    Clin Neuropharmacol; 2010 May; 33(3):129-34. PubMed ID: 20502132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
    Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
    J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simvastatin and atorvastatin on inflammation markers in plasma.
    Wiklund O; Mattsson-Hultén L; Hurt-Camejo E; Oscarsson J
    J Intern Med; 2002 Apr; 251(4):338-47. PubMed ID: 11952885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein antibody titers are reduced by statin therapy in dyslipidemic subjects: a pilot study.
    Ghayour-Mobarhan M; Lamb DJ; Vaidya N; Livingstone C; Wang T; Ferns GA
    Angiology; 2005; 56(1):61-8. PubMed ID: 15678257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients.
    Ascer E; Bertolami MC; Venturinelli ML; Buccheri V; Souza J; Nicolau JC; Ramires JA; Serrano CV
    Atherosclerosis; 2004 Nov; 177(1):161-6. PubMed ID: 15488879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.
    Paolisso G; Barbagallo M; Petrella G; Ragno E; Barbieri M; Giordano M; Varricchio M
    Atherosclerosis; 2000 May; 150(1):121-7. PubMed ID: 10781642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
    Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.
    Mulder DJ; van Haelst PL; Wobbes MH; Gans RO; Zijlstra F; May JF; Smit AJ; Tervaert JW; van Doormaal JJ
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):91-7. PubMed ID: 17342417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
    Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
    Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin.
    Jacobson TA; Wertz DA; Kuznik A; Cziraky M
    Curr Med Res Opin; 2013 Jul; 29(7):773-81. PubMed ID: 23647370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
    Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS
    Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin.
    Nawawi H; Osman NS; Annuar R; Khalid BA; Yusoff K
    Atherosclerosis; 2003 Aug; 169(2):283-91. PubMed ID: 12921980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of atorvastatin and simvastatin on oxidative stress in patients at high risk for cardiovascular disease.
    Scheffer PG; Schindhelm RK; van Verschuer VM; Groenemeijer M; Simsek S; Smulders YM; Nanayakkara PW
    Neth J Med; 2013 Sep; 71(7):359-65. PubMed ID: 24038561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease.
    Li J; Sun YM; Wang LF; Li ZQ; Pan W; Cao HY
    Clin Cardiol; 2010 Apr; 33(4):222-7. PubMed ID: 20394043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic effects of atorvastatin versus simvastatin.
    Kadikoylu G; Yukselen V; Yavasoglu I; Bolaman Z
    Ann Pharmacother; 2003 Apr; 37(4):478-84. PubMed ID: 12659599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice.
    Rublee DA; Burke JP
    Postgrad Med; 2010 Mar; 122(2):16-24. PubMed ID: 20203452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxidation stress, insulin resistance and endothelial dysfunction during the treatment of hyperlipidaemia].
    Zeman M; Vecka M; Stopka P; Zahin M; Tvrzická E; Stanková B; Vareka T; Janíková L; Zák A
    Cas Lek Cesk; 2006; 145(12):923-8. PubMed ID: 17323614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.